Esther de Jong

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell–attracting chemokine (CTACK) levels in allergic diseases

DirkJan Hijnen, Marjolein de Bruin‐Weller, Bert Oosting et al. · Journal of Allergy and Clinical Immunology · 2004 · 261 citations · Full text

Commensal Gram‐negative bacteria prime human dendritic cells for enhanced IL‐23 and IL‐27 expression and enhanced Th1 development

Hermelijn H. Smits, Astrid J. van Beelen, Christina Hessle et al. · European Journal of Immunology · 2004 · 186 citations

Innate Immune System, Immunology, Immune Regulation +23

The Use of In Vitro Toxicity Data and Physiologically Based Kinetic Modeling to Predict Dose-Response Curves for In Vivo Developmental Toxicity of Glycol Ethers in Rat and Man

Jochem Louisse, Esther de Jong, Johannes J.M. van de Sandt et al. · Toxicological Sciences · 2010 · 153 citations · Full text

Predict Dose-response Curves, Systemic Toxicity, Physiologically-based Pharmacokinetic Modeling +18

Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles

Esther de Jong, Marta Barenys, Sanne A.B. Hermsen et al. · Toxicology and Applied Pharmacology · 2011 · 104 citations

Embryo Culture, Developmental Biology, Zebrafish Embryotoxicity Test +13

Relative Developmental Toxicity of Glycol Ether Alkoxy Acid Metabolites in the Embryonic Stem Cell Test as compared with the In Vivo Potency of their Parent Compounds

Esther de Jong, Jochem Louisse, Miriam Verwei et al. · Toxicological Sciences · 2009 · 70 citations

Relative Developmental Toxicity, Secondary Metabolite, Parent Compounds +18